ASND vs. MDGL: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ASND and MDGL, comparing key factors like performance, valuation metrics, dividends, and financial strength.
Company Overview
ASND’s market capitalization of 10.45 billion USD is substantially larger than MDGL’s 6.18 billion USD, indicating a significant difference in their market valuations.
ASND has a positive beta (0.36), indicating it generally moves with the broader market, whereas MDGL has a negative beta (-1.08), often moving inversely, which can offer diversification or hedging benefits.
ASND trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, MDGL is a standard domestic listing.
Symbol | ASND | MDGL |
---|---|---|
Company Name | Ascendis Pharma A/S | Madrigal Pharmaceuticals, Inc. |
Country | DK | US |
Sector | Healthcare | Healthcare |
Industry | Biotechnology | Biotechnology |
CEO | Mr. Jan Moller Mikkelsen | Mr. William J. Sibold |
Price | 173.06 USD | 278.23 USD |
Market Cap | 10.45 billion USD | 6.18 billion USD |
Beta | 0.36 | -1.08 |
Exchange | NASDAQ | NASDAQ |
IPO Date | January 28, 2015 | February 6, 2007 |
ADR | Yes | No |
Performance Comparison
This chart compares the performance of ASND and MDGL over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
This section compares the market valuation of ASND and MDGL. Key takeaways regarding their valuation, when viewed within their industry context, are presented in the commentary that follows.
- ASND’s Price-to-Earnings (P/E) ratio of -26.69 and MDGL’s P/E ratio of -15.70 both indicate negative earnings. For ASND, this signifies current unprofitability, raising questions about its operational efficiency or market conditions. MDGL’s negative P/E also reflects a lack of current earnings, a key concern for its financial health and investor appeal.
- ASND’s Forward PEG ratio of -2.42 and MDGL’s Forward PEG ratio of -0.85 are both in the negative range. For ASND, a negative PEG ratio often stems from negative current earnings or forecasts of declining earnings, making its valuation difficult to assess relative to growth. Similarly, MDGL’s negative PEG suggests underlying issues with profitability or growth expectations, raising questions about its stock price compared to future prospects.
- ASND’s Price-to-Book (P/B) ratio of -48.04 reflects a negative book value (meaning negative shareholder equity). This is a significant indicator of financial distress and raises substantial concerns about its solvency.
Symbol | ASND | MDGL |
---|---|---|
Price-to-Earnings Ratio (P/E, TTM) | -26.69 | -15.70 |
Forward PEG Ratio (TTM) | -2.42 | -0.85 |
Price-to-Sales Ratio (P/S, TTM) | 24.88 | 19.46 |
Price-to-Book Ratio (P/B, TTM) | -48.04 | 8.65 |
EV-to-EBITDA (TTM) | -38.73 | -16.25 |
EV-to-Sales (TTM) | 25.77 | 19.26 |
Dividend Comparison
Neither ASND nor MDGL currently pays a dividend; this often suggests they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.
Symbol | ASND | MDGL |
---|---|---|
Dividend Yield (TTM) | 0.00% | 0.00% |
Financial Strength Metrics Comparison
This section evaluates the financial strength of ASND and MDGL. Noteworthy observations on their financial resilience, considered from an industry perspective, are detailed in the points that follow.
- ASND’s Debt-to-Equity (D/E) ratio of -4.46 indicates negative shareholder equity. This is a significant red flag, suggesting its liabilities exceed its assets and posing a considerable threat to its long-term financial health.
- ASND’s Interest Coverage Ratio (ICR) of -3.72 and MDGL’s ICR of -30.09 are both negative. For ASND, a negative ICR means its operating earnings are insufficient to cover its interest expenses, a critical indicator of financial distress. MDGL’s negative ICR likewise signals severe difficulty in servicing its debt and raises concerns about its ongoing financial stability.
Symbol | ASND | MDGL |
---|---|---|
Current Ratio (TTM) | 1.04 | 5.91 |
Quick Ratio (TTM) | 0.71 | 5.58 |
Debt-to-Equity Ratio (TTM) | -4.46 | 0.17 |
Debt-to-Asset Ratio (TTM) | 0.80 | 0.12 |
Net Debt-to-EBITDA Ratio (TTM) | -1.34 | 0.17 |
Interest Coverage Ratio (TTM) | -3.72 | -30.09 |